基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Hombeck Torsten. Director active across 2 companies, notably Aspira Women's Health Inc.. Cumulatively, 4 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €12k. Activity tracked since 24 July 2023. The latest transaction was filed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Hombeck Torsten is a declarant linked to Aspira Women's Health Inc. and Akari Therapeutics Plc, where he is Chief Financial Officer and CFO. Across the 4 filings on record, all 4 are in the sampled recent filings, which cover the period from 2023-07-24 to 2025-01-13, with EUR 11740 of buys and EUR 0 of sells, and a transaction nature shown as Attribution.